Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01780441 · ClinicalTrials.gov registry record
Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 166
- Enrollment target
NCT01780441: Completed study, sponsored by Boston Children's Hospital.
NCT01780441 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 166 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01780441 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 166 participants
- Enrollment target
Study Summary
The investigators are enrolling 3-12 month old infants with a diagnosis of tuberous sclerosis complex (TSC) for a new study on early markers of autism. The study is looking for early signs for autism in a population (TSC) where autism is common. The goal of this project is to use behavioral testing, MRI and EEG techniques to identify children at risk for developing autism starting at 3 months of age and continuing until 36 months of age. Throughout the study, the investigators will recommend Early Intervention services for any child who shows early signs of autism.
Primary Outcome
The ADOS performed at 24 and 36 months will be used as a preliminary diagnosis for data analysis. The primary outcome is the possible clinical diagnosis of autism spectrum disorder per the DSM 5 guidelines (Autistic Disorder, Asperger's and PDD-NOS).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2013-01 |
| Est. Completion | 2020-12 |
What the finished NCT01780441 record still lists
NCT01780441 is an observational study that tracks outcomes without assigning an intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01780441 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01780441 about?
NCT01780441 is a clinical study titled "Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)". The investigators are enrolling 3-12 month old infants with a diagnosis of tuberous sclerosis complex (TSC) for a new study on early markers of autism. The study is looking for early signs for autism in a population (TSC) where autism is common. The goal of this project is to use behavioral testing,...
What is the current status of trial NCT01780441?
This trial is currently completed. The enrollment target is 166 participants. The study started on 2013-01. Estimated completion is 2020-12.
Who is sponsoring clinical trial NCT01780441?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia